# Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole in Clozapine-resistant Schizophrenia

> **NCT06501339** · PHASE4 · NOT_YET_RECRUITING · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 40 (estimated)

## Conditions studied

- Clozapine Resistant Schizophrenia

## Interventions

- **PROCEDURE:** maintenance ECT
- **DRUG:** Aripiprazole tablet

## Key facts

- **NCT ID:** NCT06501339
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-10
- **Primary completion:** 2025-10-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06501339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06501339, "Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole in Clozapine-resistant Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06501339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*